Tumor Physiology and Biology of the Ovary
Lab publications
03/10/2022
Journal of Endocrinology
Histidine decarboxylase inhibitors: a novel therapeutic option for the treatment of leydigioma
Adriana María Belén Abiuso, María Luisa Varela, Trinidad Raices, Griselda Irusta, Juan Manuel Lazzati, Marcos Besio Moreno, Alina Cavallotti, Alicia Belgorosky, Omar Pedro Pignataro, Esperanza Berensztein, Carolina Mondillo
15/08/2018
International Journal of Cancer
CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease
Porretti J, Dalton GN, Massillo C, Scalise GD, Farré PL, Elble R, Gerez EN, Accialini P, Cabanillas AM, Gardner K, De Luca P, De Siervi A.
01/05/2018
Human Reproduction
Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure
Pascuali N, Scotti L, Di Pietro M, Oubiña G, Bas D, May M, Gómez Muñoz A, Cuasnicú PS, Cohen DJ, Tesone M, Abramovich D, Parborell F.